DarioHealth Management
Management criteria checks 3/4
DarioHealth's CEO is Erez Raphael, appointed in Aug 2013, has a tenure of 10.75 years. total yearly compensation is $722.19K, comprised of 61.8% salary and 38.2% bonuses, including company stock and options. directly owns 4.99% of the company’s shares, worth $2.16M. The average tenure of the management team and the board of directors is 1.8 years and 4.2 years respectively.
Key information
Erez Raphael
Chief executive officer
US$722.2k
Total compensation
| CEO salary percentage | 61.8% |
| CEO tenure | 10.8yrs |
| CEO ownership | 5.0% |
| Management average tenure | 1.8yrs |
| Board average tenure | 4.2yrs |
Recent management updates
Recent updates
DarioHealth Corp. (NASDAQ:DRIO) Shares Could Be 23% Below Their Intrinsic Value Estimate
Feb 16
Time To Worry? Analysts Just Downgraded Their DarioHealth Corp. (NASDAQ:DRIO) Outlook
Nov 06Is DarioHealth (NASDAQ:DRIO) Using Debt Sensibly?
Oct 07Market Cool On DarioHealth Corp.'s (NASDAQ:DRIO) Revenues Pushing Shares 28% Lower
Aug 16Need To Know: Analysts Just Made A Substantial Cut To Their DarioHealth Corp. (NASDAQ:DRIO) Estimates
Aug 15DarioHealth Corp. (NASDAQ:DRIO) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Aug 13DarioHealth (NASDAQ:DRIO) Is Using Debt Safely
Oct 05Need To Know: The Consensus Just Cut Its DarioHealth Corp. (NASDAQ:DRIO) Estimates For 2022
Aug 24DarioHealth Q2 2022 Earnings Preview
Aug 12DarioHealth: Paying 1.6x Equity Value For Cash Flows Priced Into The Future
Jul 29At US$8.95, Is It Time To Put DarioHealth Corp. (NASDAQ:DRIO) On Your Watch List?
Feb 11DarioHealth: Moving Towards An Inflection Point
Nov 30DarioHealth to be a part of Russell 2000 and 3000 Indexes
Jun 15We Think DarioHealth (NASDAQ:DRIO) Can Afford To Drive Business Growth
Jun 07CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$722k | US$446k | -US$55m |
| Sep 30 2023 | n/a | n/a | -US$57m |
| Jun 30 2023 | n/a | n/a | -US$58m |
| Mar 31 2023 | n/a | n/a | -US$58m |
| Dec 31 2022 | US$3m | US$490k | -US$60m |
| Sep 30 2022 | n/a | n/a | -US$65m |
| Jun 30 2022 | n/a | n/a | -US$73m |
| Mar 31 2022 | n/a | n/a | -US$72m |
| Dec 31 2021 | US$8m | US$461k | -US$68m |
| Sep 30 2021 | n/a | n/a | -US$58m |
| Jun 30 2021 | n/a | n/a | -US$43m |
| Mar 31 2021 | n/a | n/a | -US$32m |
| Dec 31 2020 | US$3m | US$284k | -US$33m |
| Sep 30 2020 | n/a | n/a | -US$31m |
| Jun 30 2020 | n/a | n/a | -US$26m |
| Mar 31 2020 | n/a | n/a | -US$27m |
| Dec 31 2019 | US$1m | US$249k | -US$21m |
| Sep 30 2019 | n/a | n/a | -US$19m |
| Jun 30 2019 | n/a | n/a | -US$20m |
| Mar 31 2019 | n/a | n/a | -US$21m |
| Dec 31 2018 | US$2m | US$205k | -US$18m |
| Sep 30 2018 | n/a | n/a | -US$17m |
| Jun 30 2018 | n/a | n/a | -US$16m |
| Mar 31 2018 | n/a | n/a | -US$14m |
| Dec 31 2017 | US$2m | US$147k | -US$16m |
Compensation vs Market: Erez's total compensation ($USD722.19K) is about average for companies of similar size in the US market ($USD674.46K).
Compensation vs Earnings: Erez's compensation has been consistent with company performance over the past year.
CEO
Erez Raphael (50 yo)
10.8yrs
Tenure
US$722,187
Compensation
Mr. Erez Raphael has been the Chief Executive Officer of DarioHealth Corp. since August 9, 2013 and has been its Director since December 2013. Mr. Raphael served as the President of DarioHealth Corp. since...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 10.8yrs | US$722.19k | 4.99% $ 2.2m | |
| President | 1.8yrs | US$536.65k | 0.32% $ 137.1k | |
| CFO, Treasurer & Secretary | 9.3yrs | US$342.58k | 1.82% $ 790.1k | |
| Co-Founder & Production Chief | no data | no data | no data | |
| Chief Operating Officer | less than a year | no data | no data | |
| Senior Vice President of Operations & Compliance | no data | no data | no data | |
| Content & Communications Manager | no data | no data | no data | |
| Vice President of Marketing | 1.8yrs | no data | no data | |
| Chief People Officer | less than a year | no data | no data | |
| Head of Commercialization North America | 6.1yrs | no data | no data | |
| Chief Medical Officer | 4.2yrs | no data | no data | |
| Senior VP of R&D and Delivery Solutions | less than a year | no data | no data |
1.8yrs
Average Tenure
53yo
Average Age
Experienced Management: DRIO's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 10.4yrs | US$722.19k | 4.99% $ 2.2m | |
| Member of Advisory Board | no data | no data | no data | |
| Member of the Scientific Advisory Board | 3.3yrs | no data | no data | |
| Independent Director | 10.5yrs | US$70.00k | 0.32% $ 140.8k | |
| Director | 4.2yrs | US$50.00k | 1.31% $ 566.4k | |
| Independent Director | 3.8yrs | US$70.00k | 0.45% $ 193.4k | |
| Chairman of Scientific Advisory Board | 3.7yrs | no data | no data | |
| Independent Director | 9.5yrs | US$70.00k | 0.55% $ 236.5k | |
| Member of Advisory Board | 2.3yrs | US$166.16k | no data | |
| Independent Chairman | 5.8yrs | US$70.00k | 0.70% $ 305.1k | |
| Member of Advisory Board | 4.6yrs | no data | no data | |
| Member of the Scientific Advisory Board | 3.3yrs | no data | no data |
4.2yrs
Average Tenure
59yo
Average Age
Experienced Board: DRIO's board of directors are considered experienced (4.2 years average tenure).